PRODUCTS SERVICES COMPANY CONTACT FAQ

Search Dictionary Mobile

Login

J A Wedzicha Selected Research

Chronic Obstructive Pulmonary Disease (COPD)

02/2008	Outcomes for COPD pharmacological trials: from lung function to biomarkers.
09/2007	Effect of tiotropium on sputum and serum inflammatory markers and exacerbations in COPD.
03/2007	What is (and what is not) a COPD exacerbation: thoughts from the new GOLD guidelines.
12/2005	Inhaled corticosteroids in COPD: a light at the end of the tunnel?
12/2005	Effects of exacerbations and seasonality on exhaled nitric oxide in COPD.
01/2005	MMP-9, TIMP-1 and inflammatory cells in sputum from COPD patients during exacerbation.
01/2004	Non-invasive positive pressure ventilation for treatment of respiratory failure due to exacerbations of chronic obstructive pulmonary disease.
01/2004	Non-invasive positive pressure ventilation for treatment of respiratory failure due to exacerbations of chronic obstructive pulmonary disease.
01/2003	Non-invasive positive pressure ventilation for treatment of respiratory failure due to exacerbations of chronic obstructive pulmonary disease.
01/2002	Ambulatory oxygen for chronic obstructive pulmonary disease.
01/2001	Sputum and plasma endothelin-1 levels in exacerbations of chronic obstructive pulmonary disease.
10/2000	Randomized controlled trial of domiciliary noninvasive positive pressure ventilation and physical training in severe chronic obstructive pulmonary disease.
08/2000	Oral corticosteroids for exacerbations of chronic obstructive pulmonary disease.
08/2000	Acute exacerbations of chronic obstructive pulmonary disease are accompanied by elevations of plasma fibrinogen and serum IL-6 levels.

Articles by Research Topic

Disease

14	Chronic Obstructive Pulmonary Disease (COPD) 02/2008 - 08/2000
5	Respiratory Insufficiency (Respiratory Failure) 01/2005 - 01/2003
2	Asthma (Bronchial Asthma) 01/2005 - 01/2005
1	Cheyne-Stokes Respiration 11/2005
1	Cardiac Arrhythmias (Arrythmia) 11/2005

Drug/Important Bio-Agent (IBA)

2	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2005 - 08/2000
1	Biological Markers (Surrogate Marker)IBA 02/2008
1	tiotropium (Spiriva)FDA Link 09/2007
1	GoldIBA 03/2007
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2005
1	Tissue Inhibitor of Metalloproteinase-1IBA 01/2005
1	OxygenIBA 01/2002
1	Endothelin-1 (Endothelin 1)IBA 01/2001
1	Fibrinogen (Factor I)IBA 08/2000
1	Interleukin-6 (Interleukin 6)IBA 08/2000

Therapy/Procedure

6	Positive-Pressure Respiration (PEEP) 01/2005 - 10/2000
1	Defibrillators (Defibrillator) 11/2005